CASI Historical PE Ratio image   This CASI PE ratio history page last updated 11/15/2022
CASI PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/14/2022
1.89-0.38-1.94NA
Q2 2022
8/12/2022
3.48-0.56-2.26NA
Q1 2022
5/12/2022
3.10-0.60-2.20NA
Q4 2021
3/28/2022
9.10-0.40-2.70NA
Q3 2021
11/12/2021
10.80-0.70-3.50NA
Q2 2021
8/12/2021
11.60-0.50-4.20NA
Q1 2021
5/13/2021
14.20-1.10-4.60NA
Q4 2020
3/30/2021
19.90-1.20-4.40NA
Q3 2020
11/9/2020
19.20-1.40-4.50NA
Q2 2020
8/10/2020
19.10-0.90-4.10NA
Q1 2020
5/11/2020
17.40-0.90-4.80NA
Q4 2019
3/16/2020
14.40-1.30-4.80NA
Q3 2019
11/12/2019
32.40-1.00-4.50NA
Q2 2019
8/9/2019
30.20-1.60-4.50NA
Q1 2019
5/15/2019
31.80-0.90-3.60NA
Q4 2018
3/29/2019
28.70-1.00-3.10NA
Q3 2018
11/14/2018
33.30-1.00-2.90NA
Q2 2018
8/14/2018
78.60-0.70-2.20NA
Q1 2018
5/15/2018
79.80-0.40-1.90NA
Q4 2017
3/29/2018
41.70-0.80-1.80NA
Q3 2017
11/14/2017
27.20-0.30-1.50NA
Q2 2017
8/14/2017
9.90-0.40-1.50NA
Q1 2017
5/15/2017
10.30-0.30-1.90NA
Q4 2016
3/31/2017
14.20-0.50-2.00NA
Q3 2016
11/14/2016
14.80-0.30-2.00NA
Q2 2016
8/15/2016
10.30-0.80-2.40NA
Q1 2016
5/13/2016
12.30-0.40-2.20NA
Q4 2015
3/28/2016
11.90-0.50-2.40NA
Q3 2015
11/13/2015
12.40-0.70-2.40NA
Q2 2015
8/14/2015
15.30-0.60-9.40NA
Q1 2015
5/15/2015
14.50-0.60-9.50NA
Q4 2014
3/27/2015
14.80-0.50-9.40NA
Q3 2014
11/14/2014
15.60-7.70NANA
Q2 2014
8/14/2014
18.70-0.70NANA
Q1 2014
5/15/2014
17.70-0.50NANA
CASI Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/14/2022
1.89-0.38-1.52NA
Q2 2022
8/12/2022
3.48-0.56-2.24NA
Q1 2022
5/12/2022
3.10-0.60-2.40NA
Q4 2021
3/28/2022
9.10-0.40-1.60NA
Q3 2021
11/12/2021
10.80-0.70-2.80NA
Q2 2021
8/12/2021
11.60-0.50-2.00NA
Q1 2021
5/13/2021
14.20-1.10-4.40NA
Q4 2020
3/30/2021
19.90-1.20-4.80NA
Q3 2020
11/9/2020
19.20-1.40-5.60NA
Q2 2020
8/10/2020
19.10-0.90-3.60NA
Q1 2020
5/11/2020
17.40-0.90-3.60NA
Q4 2019
3/16/2020
14.40-1.30-5.20NA
Q3 2019
11/12/2019
32.40-1.00-4.00NA
Q2 2019
8/9/2019
30.20-1.60-6.40NA
Q1 2019
5/15/2019
31.80-0.90-3.60NA
Q4 2018
3/29/2019
28.70-1.00-4.00NA
Q3 2018
11/14/2018
33.30-1.00-4.00NA
Q2 2018
8/14/2018
78.60-0.70-2.80NA
Q1 2018
5/15/2018
79.80-0.40-1.60NA
Q4 2017
3/29/2018
41.70-0.80-3.20NA
Q3 2017
11/14/2017
27.20-0.30-1.20NA
Q2 2017
8/14/2017
9.90-0.40-1.60NA
Q1 2017
5/15/2017
10.30-0.30-1.20NA
Q4 2016
3/31/2017
14.20-0.50-2.00NA
Q3 2016
11/14/2016
14.80-0.30-1.20NA
Q2 2016
8/15/2016
10.30-0.80-3.20NA
Q1 2016
5/13/2016
12.30-0.40-1.60NA
Q4 2015
3/28/2016
11.90-0.50-2.00NA
Q3 2015
11/13/2015
12.40-0.70-2.80NA
Q2 2015
8/14/2015
15.30-0.60-2.40NA
Q1 2015
5/15/2015
14.50-0.60-2.40NA
Q4 2014
3/27/2015
14.80-0.50-2.00NA
Q3 2014
11/14/2014
15.60-7.70-30.80NA
Q2 2014
8/14/2014
18.70-0.70-2.80NA
Q1 2014
5/15/2014
17.70-0.50-2.00NA
Quotes delayed 20 minutes

Email EnvelopeFree CASI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
CASI Pharmaceuticals (CASI) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CATB PE Ratio History
CBAY PE Ratio History
CBIO PE Ratio History
CCCC PE Ratio History
CCEL PE Ratio History
CCRN PE Ratio History
CCXI PE Ratio History
CDAK PE Ratio History
CDMO PE Ratio History
CDNA PE Ratio History
On this page we presented the CASI PE Ratio History information for CASI Pharmaceuticals' stock. The average CASI PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CASI PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CASI PE ratio history result, against the recent PE: when this page was posted on 11/14/2022, the most recent closing price for CASI had been 1.89, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on CASI or any other given stock, valuation analysis for CASI can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate CASI Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for CASI. Thanks for visiting, and the next time you need to research CASI PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: HNST Insider Buying, AAP Dividend Growth Rate, Funds Holding CBRE.

 

CASI PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.